The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011
Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Macrophage released TNF-related apoptosis-inducing ligand (TRAIL) impairs alveolar fluid clearance after Influenza A virus infection Source: Lung Science Conference 2015 Year: 2015
Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009
Expression and function of Fas receptor (CD95) and Fas ligand (FasL) on T cells in atopic bronchial asthma (ABA): the role of glucocorticoid (GC)-therapy Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005
Oral presentation: Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009
Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011
TRAIL and Bax-mediated apoptosis, pathways by which apoptosis may be induced in emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006
Endotoxin induces proliferation of NSCLC cells by a COX-2 dependent manner – Role of CD14, TLRs and EGFR signaling Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
A role for soluble Fas ligand in neutrophil/epithelial cell apoptosis in Wegener‘s granulomatosis? Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007
Resistance to Fas-mediated apoptosis in human lung fibroblast Source: Eur Respir J 2002; 20: 359-368 Year: 2002
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
The death receptor CD95 (Fas, Apo-1) expression and Annexin-V binding of phosphatidylserine in lymphocytes in bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 757s Year: 2006
Fas activation impairs the alveolar epithelial function in mice by mechanisms involving apoptosis Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce anti-tumor immunity Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008